All News

RA,polyarticular,black,rheumatoid

Best Treatments for Immune Checkpoint Inhibitor-associated Arthritis

d Jack Cush, MD

A retrospective study of cancer patients who developed immune checkpoint inhibitor-associated inflammatory arthritis (ICI-IA) shows that biologic DMARDs were more effective than conventional synthetic DMARDs (csDMARDs) in rapid control of arthritis.

Read Article
lungs,art,red

Clinical Profile of RA-associated Interstitial Lung Disease

d Jack Cush, MD

A prospective, cross-sectional analysis of patients with rheumatoid arthritis (RA) shows those with interstitial lung disease (ILD) tend to be older, obese and have a smoking history.

Read Article
scale decision balance question

Female Force

d Susan Shenoi, MD, MS

In medicine, a field where burnout is becoming the norm, there is much promotion of the idea of work-life balance. In reality, the scales between work and life aren’t really balanced. Is the potential for change on the horizon?

Read Article
Rheumatologist - Work-Life Survey Results Last week, registered Rheumatologists responded to an email survey regarding work-life balance. The following are the results from 190 respondents - 53% were male (47% female) and 94% were from the USA. https://t.co/2g7oL6ltAo https://t.co/uYv7sDyO9o

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Megan Clowse discusses the differences in pregnancy planning for men and women with rheumatic disease, with particular focus on medication use. Watch now. https://t.co/Ine8CdbZR4 https://t.co/7UnanlnQcC

Links:

Dr. John Cush RheumNow ( View Tweet)
FDA FAERS study of IL-17 inhib & colitis: 388 pts w/ suspected IL-17i assoc. IBD. Median age - 42 yrs; Initial Sxs= diarrhea 91%, Abd pain 58%, bloody diarrhea 51%), & fever 36%, ^WBC 87%; Time to onset=2.9 mos. Time to remission after IL-17i D/C =4 wks https://t.co/adrtUhFj9C https://t.co/61GC5hvzYV

Links:

Dr. John Cush RheumNow ( View Tweet)
Retrospective study of 42 pts w/ cocaine-induced midline or systemic vasculitis; Current cocaine use common (20/23 + urine tox, including pts who prev. deniedcocaine). Found: septal perfs (75%), oronasal fistula(15%), less(27%) systemic Sxs, 56% PR3-ANCA+https://t.co/z1Z4INRSj5 https://t.co/v9ZyZD1Lrb

Links:

Dr. John Cush RheumNow ( View Tweet)
With AI and GPT-4... "The cognitive speed limit has just been lifted." - John Nosta https://t.co/mMXos8LLt6 https://t.co/imBfp37J1l

Links:

Dr. John Cush RheumNow ( View Tweet)
Spanish Society of Rheumatology (SER) study finds w/ retirement of many older (male) Rheums; there are workforce shortages. Most (59.7%) of rheums in Spain are women, the majority below age 54 yrs. https://t.co/DPs0S63Aqc https://t.co/ig4kOQWmkn

Links:

Dr. John Cush RheumNow ( View Tweet)
vit D shows no change in Fx Risk. Study of 20,326 Australians given placebo or vit D3 60K IU/mo. 46% women, age 69 yrs. W/ 5.1 yrs F/U - no effect on Fx risk (HR 0·94; 0·84–1·06). Fx in 5.6% of Vit D vs 5.9% in PBO (non-vertebral, major OP & hip Fxs https://t.co/cSbTS3xWrX https://t.co/Jipzw28Wn8

Links:

Dr. John Cush RheumNow ( View Tweet)
Antiphospholipid Antibodies With Incident Cardiovascular Events Are antiphospholipid antibodies (aPL) associated with atherosclerotic cardiovascular (ASCVD) event risk? https://t.co/XQk17P6D2f https://t.co/y5exrsicW8

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumThoughts: Changing the Conversation with Patients: Lupus Join the discussion! RheumThoughts are opinion pieces from healthcare professionals. https://t.co/NcJcCZVlbE @drbags71 https://t.co/VfAqUkqLak

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Presents Women In Rheumatology: Contract Negotiations https://t.co/nkAu5kQj2w

Links:

Dr. John Cush RheumNow ( View Tweet)

TONIGHT! Tuesday Night Rheumatology addresses Contract Negotiations, featuring Andrea Liberatore, JD, Gwenesta Melton, MD, and Kathryn Dao, MD. Sign up to attend this and all of our Tuesday Night Rheumatology series. @uptoTate @KDAO2011 https://t.co/L2WMLnnJhV https://t.co/Z4kEBJHBjz

Links:

Dr. John Cush RheumNow ( View Tweet)
Probiotic strain Ligilactobacillus salivarius studied in gout (as it metabolizes purines). 30 pts w/ hyperuricemia & recurrent gout were given L. salivarius or allopurinol for 6 mos. Probiotic group had less gout attacks (5/15) than controls (13/15). https://t.co/njPZdKhBxv https://t.co/YO27M8p5Ki

Links:

Dr. John Cush RheumNow ( View Tweet)
April's Therapeutic Update focuses on gender differences in disease states and therapeutic outcomes. Sex Differences in axSpA and PsA, Gender Differences in Vasculitis, and Gender Differences in Counseling Patients on Reproductive Health now available. https://t.co/M9kUr44Zwj https://t.co/LFPpnLMK4D

Links:

Dr. John Cush RheumNow ( View Tweet)
Commercial claims analysis shows a significant association between acne and incident #IBD (OR 1.42; 1.23-1.65), but not with the drugs used to treat acne (tetracycline-class Abx or isotretinoin) https://t.co/VSHMRw4z7c https://t.co/S2o6Xw3Mfd

Links:

Dr. John Cush RheumNow ( View Tweet)

Anakinra Phase 2/3 study in severe hosp. COVID-19 pts (5/20-3/21) w/ pneumonia & hyperinflammation (incr levels IL-6, ferritin, CRP, LDH). 179 pt Rx w/ ANA or SOC - d15 need for Mech ventilation was 77% ANAK v 86% SoC (NS; RR 0.90; 0.77-1.04) https://t.co/CFcI1qTsU2 https://t.co/wAj4pHN5Dh

Links:

Dr. John Cush RheumNow ( View Tweet)
Mentoring is Personal Dr. Una Makris shares her experience finding and becoming a mentor to rheumatologists. https://t.co/MEW1b0lAnE https://t.co/kxdJ3bafsr

Links:

Dr. John Cush RheumNow ( View Tweet)
NEJM Clinical image: 61-year-old woman presented with a 6-month history of periorbital swelling and shoulder weakness. The physical examination was notable for erythema of the upper and lower eyelids and substantial periorbital edema. Dermatomyositis. https://t.co/1Vu1Lh37Hd https://t.co/Bh7FXDgMRx

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×